COMPANION MEETINGS International Society of Urological Pathology   Saturday, March 1, 2008 — 7:00 PM, Convention Center Korbel BR 2/3   Recent Advances in Urological Pathology   Moderators: Holger Moch, University Hospital of Zürich, Zürich, Switzerland and Liang Cheng, Indiana University School of Medicine, Indianapolis, IN   Disclosure: In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. The speakers have indicated they have nothing to disclose. Click the button above to add this event to your Itinerary Planner... Click here to view (or print) handout in single page format for the entire meeting. Note: Any slides will be printed in color. Click any blue title below to display and print the handout for individual lecture(s): 7:00  President's Remarks - Brett Delahunt, Wellington School of Medicine and Health Sciences, Wellington, New Zealand 7:10  Classification of Testicular Germ Cell Tumors: Insights from Immunohistochemistry - Victor E. Reuter, Memorial Sloan Kettering Cancer Center, New York, NY 7:40  Recent Developments in the Diagnosis of Adrenal Neoplasia - Ricardo V. Lloyd, Mayo Clinic and Mayo Foundation, Rochester, MN 8:10  Recent Developments in the Pathology of Renal Cell Neoplasia - John N. Eble, Indiana University School of Medicine, Indianapolis, IN 8:40  Molecular Alterations in Prostate Cancer as Diagnostic and Therapeutic Targets - Angelo De Marzo, Johns Hopkins Hospital, Baltimore, MD Topics are chosen by the ISUP President and Executive committee after extensive consultation with our Society members. The topics selected take into consideration of previous topics, needs of members and general audience and recent advances in our field. The program will provide for a better understanding of the pathogenesis of challenging and emerging diagnostic entities. The clinical utility of ancillary studies, the concepts of several new and emerging entities and the differential diagnosis will be discussed by a panel of leading experts, to support excellent in the practice of urological pathology.